During the past decade, University of Michigan-Oncology conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Michigan-Oncology" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "University of Michigan-Oncology" are "Metastatic Colorectal Cancer" (1 trials), "PI3K Pathway Activated Tumors" (1 trials), "Rectal Cancer" (1 trials) and "Tumors With CDK4/6 Pathway Activation" (1 trials). Many other conditions were trialed in "University of Michigan-Oncology" in a lesser frequency.

Most popular intervention types in "University of Michigan-Oncology" are "Drug" (4 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "BKM120" (1 trials), "Dexamethasone" (1 trials), "Folic Acid" (1 trials), "LEE011" (1 trials) and "Oxaliplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Michigan-Oncology" are 4 trials for "All" genders.

Currently, there are NaN active trials in "University of Michigan-Oncology". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in University of Michigan-Oncology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University of Michigan-Oncology, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".